Form 4: Bicycle Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Nigel Crockett, Chief Business Officer of Bicycle Therapeutics PLC, sold 967 ordinary shares to cover tax withholding obligations related to the vesting and settlement of RSUs.
Summary
- On July 3, 2024, Nigel Crockett, the Chief Business Officer of Bicycle Therapeutics PLC, sold 967 ordinary shares of the company.
- The sale was executed to cover statutory tax withholding obligations associated with the vesting and settlement of Restricted Stock Units (RSUs).
- The shares were sold at a weighted average price of $19.64, with individual transactions ranging from $19.63 to $19.69.
- Following the transaction, Crockett still beneficially owns 46,794 ordinary shares of Bicycle Therapeutics PLC.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. This transaction reflects standard compensation practices and tax management strategies.
Key Dates
| Date | Description |
|---|---|
| 07/03/2024 | Date of the share sale transaction. |
| 07/08/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.